While the drugs have grown in popularity among doctors and patients, they are generally too expensive for most people to ...

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today that it ...

That's how much new U.S. tariffs could cost Mercedes-Benz this year, according to brokerage Bernstein—14% of expected operating profit. That is before any potential retaliation by U.S. trading ...

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

The secret of the president’s dramatic weight loss is the talk of the White House, our must-read newsletter The Swamp reveals.

Our writer shows how investing regularly in a SIPP account can lead to a £1m+ portfolio for savvy investors who start early ...

A few Easter eggs too many have stopped your weight-loss goals in their tracks, but don’t allow that to cause your motivation ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...